Travere Therapeutics, Inc. (TVTX)
65.22
-0.49
(-0.75%)
USD |
NASDAQ |
Aug 24, 16:00
65.22
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics 1 Year Total Returns (Daily) : 269.4% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 269.4% |
| August 20, 2026 | 258.7% |
| August 19, 2026 | 274.1% |
| August 18, 2026 | 240.4% |
| August 17, 2026 | 237.6% |
| August 14, 2026 | 240.9% |
| August 13, 2026 | 240.3% |
| August 12, 2026 | 257.0% |
| August 11, 2026 | 248.4% |
| August 10, 2026 | 259.4% |
| August 07, 2026 | 262.6% |
| August 06, 2026 | 262.2% |
| August 05, 2026 | 276.3% |
| August 04, 2026 | 251.0% |
| August 03, 2026 | 251.8% |
| July 31, 2026 | 261.7% |
| July 30, 2026 | 270.0% |
| July 29, 2026 | 257.8% |
| July 28, 2026 | 263.1% |
| July 27, 2026 | 270.0% |
| July 24, 2026 | 259.6% |
| July 23, 2026 | 251.4% |
| July 22, 2026 | 259.3% |
| July 21, 2026 | 257.6% |
| July 20, 2026 | 244.3% |
| Date | Value |
|---|---|
| July 17, 2026 | 243.5% |
| July 16, 2026 | 231.8% |
| July 15, 2026 | 246.4% |
| July 14, 2026 | 237.4% |
| July 13, 2026 | 241.8% |
| July 10, 2026 | 241.9% |
| July 09, 2026 | 258.1% |
| July 08, 2026 | 281.4% |
| July 07, 2026 | 296.1% |
| July 06, 2026 | 282.9% |
| July 02, 2026 | 283.6% |
| July 01, 2026 | 283.0% |
| June 30, 2026 | 283.9% |
| June 29, 2026 | 294.7% |
| June 26, 2026 | 289.0% |
| June 25, 2026 | 295.0% |
| June 24, 2026 | 278.5% |
| June 23, 2026 | 286.1% |
| June 22, 2026 | 285.1% |
| June 18, 2026 | 282.7% |
| June 17, 2026 | 284.4% |
| June 16, 2026 | 263.6% |
| June 15, 2026 | 271.0% |
| June 12, 2026 | 248.3% |
| June 11, 2026 | 236.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AbbVie, Inc. | 30.40% |
| Insmed, Inc. | -5.15% |
| United Therapeutics Corp. | 65.17% |
| Krystal Biotech, Inc. | 137.9% |
| Relay Therapeutics, Inc. | 470.1% |